Manufacturers Life Insurance Company, The Akebia Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$109 Billion
Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 75,617 shares of AKBA stock, worth $144,428. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,617

Previous 78,444 3.6%

Holding current value

$144,428

Previous $103,000 35.92%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.26 - $2.13 $3,562 - $6,021	-2,827 Reduced 3.6%	75,617 $140,000
Q3 2024 Nov 13, 2024	BUY	$0.94 - $1.55 $73,737 - $121,588	78,444 New	78,444 $103,000
Q2 2022 Aug 15, 2022	SELL	$0.32 - $0.67 $25,195 - $52,753	-78,736 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$0.72 - $2.93 $56,689 - $230,696	78,736 New	78,736 $56,000
Q1 2022 May 20, 2022	SELL	$0.72 - $2.93 $14,552 - $59,221	-20,212 Reduced 20.43%	78,736 $57,000
Q4 2021 Feb 16, 2022	SELL	$2.26 - $3.34 $8,908 - $13,166	-3,942 Reduced 3.83%	98,948 $224,000
Q3 2021 Nov 12, 2021	BUY	$2.35 - $3.88 $18,659 - $30,807	7,940 Added 8.36%	102,890 $296,000
Q2 2021 Aug 12, 2021	BUY	$2.83 - $4.2 $17,786 - $26,397	6,285 Added 7.09%	94,950 $360,000
Q1 2021 May 03, 2021	SELL	$2.92 - $5.06 $5,215 - $9,037	-1,786 Reduced 1.97%	88,665 $300,000
Q4 2020 Feb 12, 2021	BUY	$2.22 - $3.78 $20,215 - $34,420	9,106 Added 11.19%	90,451 $253,000
Q3 2020 Nov 09, 2020	BUY	$2.39 - $13.08 $9,246 - $50,606	3,869 Added 4.99%	81,345 $204,000
Q2 2020 Aug 10, 2020	BUY	$6.67 - $13.58 $10,765 - $21,918	1,614 Added 2.13%	77,476 $984,000
Q1 2020 May 15, 2020	BUY	$4.1 - $10.24 $16,125 - $40,273	3,933 Added 5.47%	75,862 $575,000
Q4 2019 Feb 14, 2020	SELL	$3.16 - $6.73 $9,486 - $20,203	-3,002 Reduced 4.01%	71,929 $455,000
Q2 2019 Aug 14, 2019	BUY	$4.1 - $8.05 $70,774 - $138,959	17,262 Added 29.93%	74,931 $363,000
Q1 2019 May 13, 2019	BUY	$5.41 - $8.73 $10,771 - $17,381	1,991 Added 3.58%	57,669 $472,000
Q4 2018 Feb 14, 2019	BUY	$5.39 - $9.15 $111,325 - $188,984	20,654 Added 58.97%	55,678 $308,000
Q3 2018 Nov 14, 2018	SELL	$7.44 - $10.65 $36,582 - $52,366	-4,917 Reduced 12.31%	35,024 $309,000
Q2 2018 Aug 14, 2018	BUY	$9.15 - $11.34 $51,423 - $63,730	5,620 Added 16.37%	39,941 $399,000
Q1 2018 May 15, 2018	SELL	$9.53 - $15.68 $3,850 - $6,334	-404 Reduced 1.16%	34,321 $327,000
Q4 2017 Feb 08, 2018	BUY	$14.24 - $19.59 $1,324 - $1,821	93 Added 0.27%	34,725 $516,000
Q3 2017 Nov 14, 2017	BUY	$13.06 - $19.67 $452,293 - $681,211	34,632	34,632 $681,000

Others Institutions Holding AKBA

# of Institutions

127

Shares Held

62.8M

Call Options Held

50.6K

Put Options Held

203K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $351M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Akebia Therapeutics, Inc. Transaction History